Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May-Jun;21(3):188-94.
doi: 10.1016/j.rpor.2016.01.005. Epub 2016 Feb 20.

Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy

Martina Becker-Schiebe  1 , Ali Abaci  2 , Tahera Ahmad  2 , Wolfgang Hoffmann  2
Affiliations

Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy

Martina Becker-Schiebe et al. Rep Pract Oncol Radiother. 2016 May-Jun.

Abstract

Aim: To determine the influence of IGRT in terms of toxicities compared to non-IGRT patients undergoing definitive RT.

Background: Image-guided radiotherapy (IGRT) enables immediate correction of target movement by online imaging. For prostate cancer patients undergoing radiation therapy (RT), a geographical miss of the prostate may result in increased dose-volume effects in the rectum and bladder.

Methods: A total of 198 prostate cancer patients treated between 2003 and 2013 were recruited randomly for this evaluation. The rates of genitourinary (GU) and gastrointestinal (GI) toxicity for 96 non-IGRT patients (total dose: 72/73.8 Gy) were compared to those for 102 IGRT patients (total dose: 77.4 Gy) according to the Common Toxicity Criteria Version 3.0 (CTCAEv3.0). Follow-up information included treatment-related symptoms and PSA relapse.

Results: After a median follow-up of 55.4 months, a statistically significant difference was noted for acute GI toxicities ≥1 in favour of IGRT. Significantly more patients treated by IGRT were free of acute GI symptoms (43% vs. 19%, p = 0.0012). In the non-IGRT group, more patients experienced acute GU side effects (89% vs. 80%, p = 0.07). Late toxicity scores were comparable for both cohorts.

Conclusions: Based on the data, we demonstrated that despite dose escalation, IGRT enabled us to reduce the GI side effects of radiation. IGRT can therefore be considered to be the standard of care for dose-escalated RT of localized prostate cancer.

Keywords: Acute toxicity; Image guidance; Late toxicity; Prostate cancer; Radiotherapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of acute gastrointestinal toxicity in IGRT vs. non-IGRT patients, p < 0.05.
See this image and copyright information in PMC

References

    1. Zietman A.L., DeSilvio M.L., Slater J.D. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J Am Med Assoc. 2005;294:1233–1239. - PubMed
    1. Cahlon O., Zelefsky M.J., Shippy A. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys. 2008;71:330–337. - PubMed
    1. Pollack A., Zagars G.K., Smith L.G. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000;18:3904–3911. - PubMed
    1. Ghadjar P., Vock J., Vetterli D. Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking. Radiat Oncol. 2008;3:35. - PMC - PubMed
    1. Michalski J.M., Yan Y., Watkins-Bruner D. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87(5):932–938. - PMC - PubMed